8-K/A
filed December 31, 2024, 6:59 PM ET
ticker BNTC
CIK 0001808898
leadership
confidence high
sentiment neutral
materiality 0.25
Benitec Biopharma grants COO Sophie Mukadam 300,000 options at $12.00
Benitec Biopharma Inc.
- Sophie Mukadam appointed COO effective Jan 1, 2025; receives 300,000 nonqualified stock options.
- Exercise price $12.00 per share, equal to closing price on grant date Dec 27, 2024.
- Vesting in 16 equal quarterly installments starting Mar 31, 2025, conditioned on continued service.
- Unvested options fully accelerate upon a Change in Control as defined in the Plan.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-24-287065
- form_type
- 8-K/A
- ticker
- BNTC
- cik
- 0001808898
- company_name
- Benitec Biopharma Inc.
- filed_at
- 2024-12-31T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:09.728720+00:00
- generated_at
- 2026-05-28T21:58:45.012812+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.25
- calibrated_materiality_score
- 0.25
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-24-287065
- json_url
- https://secwatch.observer/filing/0001193125-24-287065.json
- markdown_url
- https://secwatch.observer/filing/0001193125-24-287065.md
- text_url
- https://secwatch.observer/filing/0001193125-24-287065.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1808898/000119312524287065/0001193125-24-287065-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1808898/000119312524287065/d905396d8ka.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
MZYX
MOZAYYX Acquisition appoints Emma Rose Bienvenu as independent director
MOZAYYX Acquisition Corp.
June 1, 2026, 5:00 PM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
JOB
Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments
GEE Group Inc.
June 1, 2026, 4:47 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
SERA
Sera Prognostics director Jeff Elliott resigns ahead of annual meeting
SERA PROGNOSTICS, INC.
June 1, 2026, 4:44 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
FTI
TechnipFMC appoints Eric D. Mullins to Board of Directors effective June 1, 2026
TechnipFMC plc
June 1, 2026, 4:38 PM ET
leadership
Items 5.02, 7.01, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
MCRB
Seres Therapeutics board member Hans-Juergen Woerle resigns, effective May 31, 2026
Seres Therapeutics, Inc.
June 1, 2026, 4:30 PM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
MCHP
Microchip appoints former SVP Mitch Little to board, effective June 1, 2026
MICROCHIP TECHNOLOGY INC
June 1, 2026, 4:18 PM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
PUMP
Director Alex Volkov resigns from ProPetro board after Pioneer (Exxon) sells all shares
ProPetro Holding Corp.
June 1, 2026, 4:16 PM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
DE
Deere director Dmitri Stockton will not seek re-election at 2027 annual meeting
DEERE & CO
June 1, 2026, 4:15 PM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.